| Followers | 507 |
| Posts | 10138 |
| Boards Moderated | 0 |
| Alias Born | 04/28/2014 |
Thursday, December 07, 2017 11:31:17 AM
ECYT buy 4.75
Nasdaq stocks $1-10 with 100,000 volume
bullish divergence breakout and initial pullback
bull flag
big rally due to...
Shares of Endocyte, Inc. ECYT have soared more than 150% on Oct 2, after it acquired an exclusive worldwide license to develop and commercialize ABX GmbH’s phase III-ready prostate cancer candidate 177Lu-PSMA-617.
Also, the share price increased more than 50% in pre-market trading on Oct 3. The company made an upfront payment of $12 million to ABX.
https://finance.yahoo.com/news/endocyte-inks-deal-prostate-cancer-205808521.html
normal chart
log chart
Nasdaq stocks $1-10 with 100,000 volume
bullish divergence breakout and initial pullback
bull flag
big rally due to...
Shares of Endocyte, Inc. ECYT have soared more than 150% on Oct 2, after it acquired an exclusive worldwide license to develop and commercialize ABX GmbH’s phase III-ready prostate cancer candidate 177Lu-PSMA-617.
Also, the share price increased more than 50% in pre-market trading on Oct 3. The company made an upfront payment of $12 million to ABX.
https://finance.yahoo.com/news/endocyte-inks-deal-prostate-cancer-205808521.html
normal chart
log chart
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
